ARTICLE | Management Tracks
Dallas replaces Cunningham as CEO of Rivus
Plus: Stephen Uden named CEO at Rallybio, and updates from Alloy, TScan and more
June 29, 2023 10:38 PM UTC
Chairman Jayson Dallas was named CEO of Rivus Pharmaceuticals Inc., which is developing cardio-metabolic therapies. Dallas succeeds Allen Cunningham, who will become COO.
Rare disease company Rallybio Corp. (NASDAQ:RLYB) appointed President, COO and co-founder Stephen Uden as CEO, effective Aug. 1. Uden, who will remain president and join the board, replaces Martin Mackay who will become chairman. ...